President Trump said the Senate bill should have more “heart,” but industry experts reviewing the draft after its release today don’t believe it contains any heart at all. For one, the bill would end Medicaid expansion in 2020.
CleanSlate's growth is driven by an emerging demand for medication-assisted treatment services as well as market opportunity. With backing from growth-equity fund Apple Tree Partners, the organization is primarily expanding through new center openings.
The Medicaid Coverage for Addiction Recovery Expansion (CARE) Act would allow Medicaid payment to residential addiction treatment facilities with up to 40 beds—an increase over the current 16 bed limit. It would also allow for treatment services for up to 60 consecutive days.
A new brief from the Urban Institute shows that Medicaid programs nationwide have seen increases in buprenorphine prescriptions since the launch of the Affordable Care Act, but trends are higher in expansion states.
One of the largest referral sources for addiction treatment centers is the internet, and that channel could see some changes this year. It’s surprising that more healthcare leaders haven’t weighed in on net neutrality.
In the larger healthcare system, addiction providers have a unique position among the specialty segments. A panel of treatment center CEOs shared their insights on several emerging operational issues at the NAATP annual conference.
Treatment centers must weigh costs and clinical needs when creating policies for patient drug testing. Meanwhile, investors are examining how drug testing fits in the greater scheme of profits and regulatory risks.